ACE and Alzheimer disease: Central-acting captopril and perindopril were associated with a significantly lower incidence of AD than the use of those that cannot inhibit brain ACE (imidapril or enalapril) (odds ratio = 0.25, 95% CI = 0.08–0.75; p = 0.014).